No takes yet. Share an insight, caveat, or question.
Retrospective pharmacovigilance study identified significant safety signals in spironolactone, suggesting the need for improved monitoring.
Lin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: